Ildong Pharmaceutical and Nine & Company establish joint venture, entering cosmetics market
Predicted impact: Medium
Joint venture entering cosmetics; size undisclosed but small company with ₩90B market value.
Ildong Holdings일동홀딩스
000230 · KOSPI · ₩000230 · 일동홀딩스
₩5,670▼ ₩110 (1.90%)End-of-day · Oct 27, 2026 · End-of-day prices.
Price · 1Y −37.07%
- Market cap
- ₩65B
- Enterprise value
- ₩198B
- P/E
- 3.0×
- P/B
- 0.4×
- Dividend yield
- 1.8%
- ROE
- 12.5%
- Net margin
- 3.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−67.0% from the high
₩5,450Today: ₩5,670 – ₩5,850₩17,170
Returns
- 1W−6.1%
- 1M−4.5%
- 3M−5.0%
- 6M−43.8%
- YTD−57.3%
- 1Y−37.1%
- Volume today
- 6,781
- 0.6× the 20-day average
- Traded today
- ₩39M
- Listed shares
- 11,540,400
- EPS (12 months)
- ₩1,877
- Earnings yield 33.1%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 36 of 100 (50 is a normal day for this stock).
- SentimentPositiveNews: A new business venture into a growth market is a mildly positive step. Community: 0 bullish, 0 bearish posts this week.
- MomentumFlat-4.5% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Ildong Holdings stock overview
Ildong Holdings (일동홀딩스, KRX: 000230) is listed on KOSPI, in the Biotech & Pharma sector. Ildong Holdings is a Korean holding company that earns income from management consulting fees, brand fees, rental income, and investment returns across its group. Its shares closed at ₩5,670 on Oct 27, 2026, down 1.90% on the day, giving it a market value of ₩65B.
Key facts
- Market cap
- ₩65B
- Sector
- Biotech & Pharma
- Latest price change
- −1.90%
- As of
- Oct 27, 2026
- Main business
- Ildong Holdings is a Korean holding company that earns income from management consulting fees, brand fees, rental income, and investment returns across its group.
Quick answers about Ildong Holdings
- What does Ildong Holdings do?
- Ildong Holdings is a Korean holding company that earns income from management consulting fees, brand fees, rental income, and investment returns across its group. Its subsidiaries operate in pharmaceutical manufacturing and sales, advertising agency services, software and medical cosmetic device manufacturing, clinical pharmacology consulting, and online pharmaceutical distribution, with products and services supplied to pharmacies, clinics, and corporate clients. The group's operations are based in South Korea.
- What is the market cap of Ildong Holdings?
- The market capitalisation of Ildong Holdings was ₩65B at the close on Oct 27, 2026.
- Who are the largest shareholders of Ildong Holdings?
- According to the latest official filings, the largest reported holders are Yun Won-young (46.57%, as of Jul 16, 2026); National Pension Service (0.32%, as of Dec 31, 2025); Choi Gyu-hwan (0.05%, as of Feb 26, 2025).
- When is the next earnings report from Ildong Holdings?
- Korean companies rarely announce results dates in advance. Based on when Ildong Holdings filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
- Does the National Pension Service own Ildong Holdings?
- Yes. The National Pension Service held 0.32% of Ildong Holdings shares as of Dec 31, 2025.
Company profile
Ildong Holdings is a Korean holding company that earns income from management consulting fees, brand fees, rental income, and investment returns across its group. Its subsidiaries operate in pharmaceutical manufacturing and sales, advertising agency services, software and medical cosmetic device manufacturing, clinical pharmacology consulting, and online pharmaceutical distribution, with products and services supplied to pharmacies, clinics, and corporate clients. The group's operations are based in South Korea.
Written by AI from the company's latest annual report.
- Korean name
- 일동홀딩스
- Sector
- Biotech & Pharma
- CEO
- 최규환
- Founded
- Mar 1941
- Listed
- Jun 1975
- Listed shares
- 11,540,400
- Fiscal year ends
- Month 12
- Website
- www.ildong.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent news
Recent filings
See all- Advance Notice of Earnings Results Disclosure (Informational Disclosure)Oct 28, 2026
- [Amended Filing] Major Matters Report (Entry into Put-Back Option and Similar Agreements)Sep 30, 2026
- [Amended Filing] Major Matters Report (Entry into Put-Back Option and Similar Agreements)Sep 30, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Preliminary earnings (consolidated)Jul 30, 2026
Titles in Korean until English translations are added.
Also known as: Ildong Holdings / 일동홀딩스 / 000230 / KRX:000230
Source: KRX statistical information